原发性眼附件滤泡性淋巴瘤的临床特点和预后:回顾性分析。

IF 1.8 4区 医学 Q3 HEMATOLOGY
Shohei Nakamura, Shinichi Makita, Akiko Miyagi-Maeshima, Yoshikazu Hori, Haruhi Makino, Hirokazu Sasaki, Daiki Hattori, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Hiroshi Igaki, Shigenobu Suzuki, Koji Izutsu
{"title":"原发性眼附件滤泡性淋巴瘤的临床特点和预后:回顾性分析。","authors":"Shohei Nakamura, Shinichi Makita, Akiko Miyagi-Maeshima, Yoshikazu Hori, Haruhi Makino, Hirokazu Sasaki, Daiki Hattori, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Hiroshi Igaki, Shigenobu Suzuki, Koji Izutsu","doi":"10.1007/s12185-025-04029-6","DOIUrl":null,"url":null,"abstract":"<p><p>Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.</p>","PeriodicalId":13992,"journal":{"name":"International Journal of Hematology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical features and outcomes of primary ocular adnexal follicular lymphoma: a retrospective analysis.\",\"authors\":\"Shohei Nakamura, Shinichi Makita, Akiko Miyagi-Maeshima, Yoshikazu Hori, Haruhi Makino, Hirokazu Sasaki, Daiki Hattori, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Hiroshi Igaki, Shigenobu Suzuki, Koji Izutsu\",\"doi\":\"10.1007/s12185-025-04029-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.</p>\",\"PeriodicalId\":13992,\"journal\":{\"name\":\"International Journal of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12185-025-04029-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12185-025-04029-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

结外滤泡性淋巴瘤(FL)表现出独特的临床病理特征和预后意义,而眼附件滤泡性淋巴瘤的临床特征文献很少。在本研究中,我们回顾性分析了我院1997年至2019年间经组织学证实的眼附件滤泡性FL病例。在261例累及眼附件的淋巴瘤患者中,28例为滤泡性淋巴瘤,分期显示10例为原发性眼附件滤泡性淋巴瘤。在这10例患者中,1例因治疗信息不足而被排除。其余9例患者(6例女性)的中位年龄为62岁(范围:24-81岁)。病变位于眼眶(3例)或结膜(6例)。3例患者双侧结膜病变。8例患者最初接受放疗(其中1例患者在观察1.5年后接受放疗);另一名患者未接受治疗6.4年。中位随访7.7年,接受放疗的8例患者中有3例复发(2例在对侧结膜,1例在背部皮下组织),无野内复发。5年无进展生存率和总生存率分别为75%和100%,无组织学转化。总之,原发性眼附件滤泡性淋巴瘤在放疗和/或观察等待后预后良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical features and outcomes of primary ocular adnexal follicular lymphoma: a retrospective analysis.

Extranodal follicular lymphoma (FL) demonstrates unique clinicopathological features and prognostic implications, and the clinical characteristics of ocular adnexal FL are poorly documented. In this study, we retrospectively analyzed histologically confirmed cases of ocular adnexal FL at our institution between 1997 and 2019. Of the 261 patients with lymphoma involving the ocular adnexa, 28 had FL, and staging revealed that 10 had primary ocular adnexal FL. Of these 10 patients, one was excluded because of insufficient treatment information. The median age of the remaining nine patients (six women) was 62 (range: 24-81) years. Lesions were located in the orbit (three patients) or conjunctiva (six patients). Three patients had bilateral conjunctival lesions. Eight patients were initially treated with radiotherapy (including one who received radiotherapy after 1.5 years of observation); the other patient remained untreated for 6.4 years. With a median follow-up period of 7.7 years, three of eight patients who received radiotherapy relapsed (two in the contralateral conjunctiva, one in the subcutaneous tissue of the back), and no in-field relapses occurred. The 5-year progression-free and overall survival rates were 75% and 100%, respectively, without histological transformation. In conclusion, primary ocular adnexal FL has a favorable prognosis after radiotherapy and/or watchful waiting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
4.80%
发文量
223
审稿时长
6 months
期刊介绍: The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology. The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信